The combination of cytological analysis with KRAS mutation status improves diagnostic accuracy for cytological diagnosis of pancreatic cancers by endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) [7]. The gene discussed is KRAS; the disease is pancreatic neoplasm.